Company / Current Liabilities per Share
Anixa Biosciences Inc Current Liabilities per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.08
FY2024
5-year range
$0.06 / $0.08
FY2020-FY2024
Trend
+22.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2014 to $0.10 in FY2017.
Based on SEC 10-K filings.
0.08 in FY2024 with a 10-year CAGR of +25.0%.
Increased from $0.07 to $0.08 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- +25.0%
Key checks
Key Insights
- In FY2024, current liabilities per share increased 22.4% year-over-year.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.08 | +22.4% |
| FY2023 | $0.07 | -3.2% |
| FY2022 | $0.07 | +16.0% |
| FY2020 | $0.06 | -25.4% |
| FY2019 | $0.08 | +2.8% |
| FY2018 | $0.08 | -25.0% |
| FY2017 | $0.10 | +89.2% |
| FY2016 | $0.05 | -20.5% |
| FY2015 | $0.07 | +681.4% |
| FY2014 | $0.01 | -16.4% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026